Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo

British Journal of Dermatology

Volumn 153, Issue 5, 2005, Pages 1001-1010

  Finlan, Lee ^a   Kernohan, N M ^b   Thomson, G ^b   Beattie, P E ^b   Hupp, T R ^a   Ibbotson, S H ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

p21(WAF1 Cip1); p53; Photodynamic therapy; Psoralen plus ultraviolet A; Ultraviolet radiation

Indexed keywords

8 HYDROXYGUANINE; AMINOLEVULINIC ACID; ATM PROTEIN; ATR PROTEIN; CASEIN KINASE II; DNA; METHOXSALEN; PROTEIN KINASE; PROTEIN KINASE FACT; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SERINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ERYTHEMA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; NORMAL HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PUVA; SKIN CANCER; TREATMENT INDICATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET A RADIATION;

AMINOLEVULINIC ACID; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; HUMANS; KERATINOCYTES; OXIDATIVE STRESS; PHOSPHORYLATION; PHOTOCHEMOTHERAPY; PUVA THERAPY; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27544454162     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06922.x     Document Type: Article

References (56)

1. Tyrrell RM. UV activation of mammalian stress proteins. EXS 1996; 77:255-71.
2. Bennett WP, Hollstein MC, Hsu IC et al. Mutational spectra and immunohistochemical analyses of p53 in human cancers. Chest 1992; 101 (Suppl. 3):S19-20.
3. Greenblatt MS, Bennett WP, Hollstein MC, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.
4. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 1991; 4:445-9.
5. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992; 52:3804-6.
6. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372:773-6.
7. Kanjilal S, Strom SS, Clayman GL et al. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995; 55:3604-9.
8. Nataraj AJ, Trent JC 2nd, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem Photobiol 1995; 62:218-30.
9. Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93:14025-9.
10. Nakazawa H, English D, Randell PL et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 1994; 91:360-4.
11. Kastan MB, Onyekwere O, Sidransky D et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51:6304-11.
12. Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 1993; 75:765-78.
13. Reed M, Woelker B, Wang P et al. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc Natl Acad Sci USA 1995; 92:9455-9.
14. el-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
15. Bunz F, Dutriaux A, Lengauer C et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497-501.
16. Maeda T, Hanna AN, Sim AB et al. GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J Invest Dermatol 2002; 119:22-6.
17. Li Y, Dowbenko D, Lasky IA. AKT/TKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 2002; 277:11352-61.
18. Scott MT, Ingram A, Ball KL. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J 2002; 21:6771-80.
19. Hall PA, McKee PH, Menage HD et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8:203-7.
20. Decraene D, Agostinis P, Pupe A et al. Acute response of human skin to solar radiation: regulation and function of the p53 protein. J Photochem Photobiol B 2001; 63:78-83.
21. Campbell C, Quinn AG, Angus B et al. Wavelength specific patterns of pS3 induction in human skin following exposure to UV radiation. Cancer Res 1993; 53:2697-9.
22. Murphy M, Mabruk MJ, Lenane P et al. The expression of p53, p21, Bax and induction of apoptosis in normal volunteers in response to different doses of ultraviolet radiation. Br J Dermatol 2002; 147:110-17.
23. Davenport V, Morris JF, Motazed R, Chu AC. p53 induction in normal human skin in vitro following exposure to solar simulated UV and UV-B irradiation. J Photochem Photobiol B 1999; 49:177-86.
24. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268:2764-72.
25. Qin JZ, Bacon PE, Chaturvedi V et al. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations. Exp Dermatol 2002; 11:573-83.
26. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91:325-34.
27. Moller A, Sirma H, Hofmann TG et al. PML is required for homeo-domain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 2003; 63:4310-14.
28. Bruins W, Zwart E, Attardi LD et al. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 2004; 24:8884-94.
29. Stern RS, Beer JZ, Mills DK. Lack of consensus among experts on the choice of UV therapy for psoriasis. Arch Dermatol 1999; 135:1187-92.
30. Man I, Crombie IK, Dawe RS et al. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 2005; 152:755-7.
31. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 1997; 94:11-14.
32. Taub AF. Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol 2004; 3 (Suppl. 1):S8-25.
33. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermotol 2002; 146:552-67.
34. 32P ortho-phosphate in human fibroblasts. Oncogene 1999; 18:3788-92.
35. Craig AL, Blaydes JP, Burch LR et al. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation. Oncogene 1999; 18:6305-12.
36. Craig AL, Burch L, Vojtesek B et al. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem J 1999; 342:133-41.
37. Blaydes JP, Craig AL, Wallace M et al. Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene 2000; 19:3829-39.
38. Fotedar R, Bendjennat M, Fotedar A. Role of p21WAF1 in the cellular response to UV. Cell Cycle 2004; 3:134-7.
39. Bendjennat M, Boulaire J, Jascur T et al. UV irradiation triggers ubiquitin-dependent degradation of p21 (WAF1) to promote DNA repair. Cell 2003; 114:599-610.
40. Mass P, Hoffmann K, Gambichler T et al. Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure. Arch Dermatol Res 2003; 295:71-9.
41. Amundson SA, Patterson A, Do KT, Fornace AJ Jr. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol Ther 2002; 1:145-9.
42. waf1/ciP1. Br J Dermatol 2005; 152:1001-8.
43. Paramio JM, Lain S, Segrelles C et al. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene 1998; 17:949-57.
44. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000; 10:399-406.
45. Paramio JM, Segrelles C, Lain S et al. p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes. Mol Carcinog 2000; 29:251-62.
46. Qin JZ, Chaturvedi V, Denning MF et al. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene 2002; 21:2991-3002.
47. Nickoloff BJ, Denning M. Life and death signaling in epidermis: following a planned cell death pathway involving a trail that does not lead to skin cancer. J Invest Dermatol 2001; 117:1-2.
48. Chaturvedi V, Qin JZ, Stennett L et al. Resistance to UV-induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53. J Cell Physiol 2004; 198:100-9.
49. Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004; 6:561-70.
50. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Loser Med Surg 1996; 14:289-304.
51. Fisher AM, Ferrario A, Rucker N et al. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer Res 1999; 59:331-5.
52. Wyld L, Reed MW, Brown NJ. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 2001; 84:1384-6.
53. Heinzelmann-Schwarz V, Fedier A, Hornung R et al. Role of p53 and ATM in photodynamic therapy-induced apoptosis. Lasers Surg Med 2003; 33:182-9.
54. Hirao A, Cheung A, Duncan G et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 2002; 22:6521-32.
55. Pentland AP, Schoggins JW, Scott GA et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999; 20:1939-44.
56. Hupp TR, Lane DP, Ball KL. Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochem J 2000;352:1-17.